<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="marinedrugs-17-00567-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">marinedrugs-17-00567-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Anti-HIV-1 activity and cytotoxicity of GRFT in vitro. N/A indicates “not applicable.”</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 Type</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Line</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Anti-HIV-1 Assay Readout</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">EC
     <sub>50</sub> (nM)
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CC
     <sub>50</sub> (nM)
    </th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Ref.</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Laboratory strains and primary isolates of T- and M-tropic HIV-1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CEM-SS cells, PBMC, and macrophage</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Virus-induced cell killing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.043–0.63</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;783</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B5-marinedrugs-17-00567" ref-type="bibr">5</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CXCR4-and CCR5-tropic HIV-1, SHIV strains, and SIVmac251</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CEM-174, MT-2, MT-4, and PBMC</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p24</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;500</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B27-marinedrugs-17-00567" ref-type="bibr">27</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype C primary virus isolates</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl and PBMC</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl and p24</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B25-marinedrugs-17-00567" ref-type="bibr">25</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 CCR5-tropic strain ADA and CXCR4-tropic strain HXB2</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HeLa-ADA effector cells and HeLa-P5L CCR5-bearing target cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CCR5-tropic cell-cell fusion</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.31</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B32-marinedrugs-17-00567" ref-type="bibr">32</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 clade B and clade C isolates</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PBMCs and CD4+ MT-4 cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p24 HIV-1 core Ag ELISA</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B29-marinedrugs-17-00567" ref-type="bibr">29</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype B QH0515 and C SW7 and Du179</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raji/DC-SIGN cells and TZM-bl cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 binding to the DC-SIGN receptor</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">345</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B26-marinedrugs-17-00567" ref-type="bibr">26</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 subtype B QH0515 and C SW7 and Du179</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raji/DC-SIGN cells and TZM-bl cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 bound Raji cells transferred to CD4 cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.8–35</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B26-marinedrugs-17-00567" ref-type="bibr">26</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 X4 strain IIIB and dual-tropic R5/X4 HIV-1 strain HE</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Persistently HIV-infected T cells and noninfected CD4+ target T cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Giant cell formation</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.087</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B28-marinedrugs-17-00567" ref-type="bibr">28</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 X4 strain IIIB and dual-tropic R5/X4 HIV-1 strain HE</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Raji.DC-SIGN cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DC-SIGN mediated HIV transmission</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.025</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B28-marinedrugs-17-00567" ref-type="bibr">28</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1(IIIB) and HIV NL4.3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CEM, C8166, HuT-78, and Sup-T1 cells, Raji/DC-SIGN cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DC-SIGN-mediated virus capture</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B30-marinedrugs-17-00567" ref-type="bibr">30</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1(IIIB) and HIV NL4.3</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CEM, C8166, HuT-78, and Sup-T1 cells, Raji/DC-SIGN cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HIV-1 transmission to CD4+ T-lymphocytes</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.012</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B30-marinedrugs-17-00567" ref-type="bibr">30</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Single transmitted/founder HIV-1</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TZM-bl cells</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Neutralization assay using pseudotyped viruses</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.006–10</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N/A</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B31-marinedrugs-17-00567" ref-type="bibr">31</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
